Kiniksa Share Price
NASDAQ: KNSA | Mid Cap | HealthcareKiniksa Stock Performance
Kiniksa Share Price Today
As of 19 November 2026, Kiniksa Pharmaceuticals International, plc Class A's share price is $95.04. The stock opened at $96.48, compared to its previous close of $95.10. During today's trading session, Kiniksa Pharmaceuticals International, plc Class A's share price traded between $94.66 and $96.98, with an average price of $95.82. Over the past 52 weeks, the stock has recorded a high of $99.31 and a low of $37.09. In terms of performance, Kiniksa Pharmaceuticals International, plc Class A's share price has risen by 96.40% over the last six months and is up 123.68% on a year-on-year basis.
Kiniksa Share Price Chart
Kiniksa Quarterly Profit & Loss
All figures in USD
Kiniksa Annual Profit & Loss
All figures in USD
Kiniksa Balance Sheet
All figures in USD Million
Kiniksa Cash Flow
All figures in USD Million
About Kiniksa
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Kiniksa Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $93.18 | $94.93 | +3.13% |
Oct 2026 | $73.87 | $92.05 | +23.29% |
Sep 2026 | $78.93 | $74.66 | -6.34% |
Aug 2026 | $73.19 | $79.71 | +7.14% |
Jul 2026 | $63.51 | $74.40 | +16.40% |
Jun 2026 | $47.66 | $63.92 | +32.09% |
May 2026 | $53.38 | $48.39 | -9.96% |
Apr 2026 | $48.90 | $53.74 | +11.29% |
Mar 2026 | $44.13 | $48.29 | +8.50% |
Feb 2026 | $43.84 | $44.51 | +1.40% |
Jan 2026 | $41.50 | $43.89 | +6.58% |
Dec 2025 | $42.39 | $41.18 | -3.08% |